Net revenue of Fresenius Medical Care AG & Co. KGaA (“the Company”) was $9,720 million, up 14% compared to 2006. At constant currency, net revenue rose by 12%.

Operating income (EBIT) increased by 20% to $1,580 million compared to $1,318 million.

For the full year 2007, net income was $717 million, up 34% from 2006. Net income for 2007 increased by 25% compared to 2006 excluding the effects of one-time items in 2006.

For the eleventh consecutive year, shareholders can expect to receive an increased annual dividend. At the Annual General Meeting to be held on May 20, 2008, shareholders will be asked to approve a dividend per ordinary share of €0.54, an increase of 15% (2006: €0.47).

For the full year 2008, the Company expects to achieve revenue of more than $10.4 billion, an increase of more than 7%. Net income is expected to be between $805 million and $825 million in 2008, an increase of 12% to 15%. The Company expects to spend $650 to $750 million on capital expenditures and $150 to $250 million on acquisitions.

Fresenius SE (WKN 578560, 578563) holds approximately 36% of Fresenius Medical Care AG & Co. KGaA’s capital.

Fresenius Medical Care AG & Co. KGaA,
Represented by Fresenius Medical Care Management AG,
Board of Management,
Bad Homburg v.d.H., February 20, 2008